[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Medical Inhaled Nitric Oxide Market Growth 2024-2030

January 2024 | 79 pages | ID: G2E4767B8E71EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

According to our LPI (LP Information) latest study, the global Medical Inhaled Nitric Oxide market size was valued at US$ 1024.3 million in 2023. With growing demand in downstream market, the Medical Inhaled Nitric Oxide is forecast to a readjusted size of US$ 1913.3 million by 2030 with a CAGR of 9.3% during review period.

The research report highlights the growth potential of the global Medical Inhaled Nitric Oxide market. Medical Inhaled Nitric Oxide are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Medical Inhaled Nitric Oxide. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Medical Inhaled Nitric Oxide market.

Nitric oxide is a chemical compound in gas form that is sometimes used to treat infants with severe breathing problems associated with narrow blood vessels in the lungs. It works by relaxing smooth muscle to widen (dilate) blood vessels, especially in the lungs. Nitric oxide is usually used together with a breathing machine (ventilator). Inhaled nitric oxide (iNO) is recognized as a potent and selective pulmonary vasodilator that does not decrease systemic vascular tone. The therapeutic application of iNO in human was first described in 1990s. INO therapy was effective to improve oxygenation in infants with persistent pulmonary hypertension of the newborn (PPHN). Owing to its selective pulmonary vasodilator effects, iNO therapy is an important treatment for term newborns with hypoxemic respiratory failure due to PPHN. The Food and Drug Administration of the United States of America first approved iNO in 1999 for use as a medical gas to treat hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in term and late preterm neonates. Thereafter, iNO therapy is clinically applied to treat PPHN in term and late preterm neonates without consensus.

The main medical inhaled Nitric Oxide players include Mallinckrodt, Linde, Air Liquide, etc. The top three Medical Inhaled Nitric Oxide players account for approximately 95% of the total global market. The global medical inhaled Nitric Oxide are mainly produced in United States and Europe, they occupied for a share about 95%. North America is the largest consumer market, accounting for about 77%, followed by Europe and Asia-Pacific, with around 16% and 6% market share respectively.

Key Features:

The report on Medical Inhaled Nitric Oxide market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the Medical Inhaled Nitric Oxide market. It may include historical data, market segmentation by NO Concentration (e.g., 800 ppm, 100 ppm), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Medical Inhaled Nitric Oxide market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the Medical Inhaled Nitric Oxide market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the Medical Inhaled Nitric Oxide industry. This include advancements in Medical Inhaled Nitric Oxide technology, Medical Inhaled Nitric Oxide new entrants, Medical Inhaled Nitric Oxide new investment, and other innovations that are shaping the future of Medical Inhaled Nitric Oxide.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Medical Inhaled Nitric Oxide market. It includes factors influencing customer ' purchasing decisions, preferences for Medical Inhaled Nitric Oxide product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Medical Inhaled Nitric Oxide market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Medical Inhaled Nitric Oxide market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Medical Inhaled Nitric Oxide market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Medical Inhaled Nitric Oxide industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Medical Inhaled Nitric Oxide market.

Market Segmentation:

Medical Inhaled Nitric Oxide market is split by NO Concentration and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by NO Concentration, and by Application in terms of volume and value.

Segmentation by no concentration
  • 800 ppm
  • 100 ppm
  • Others
Segmentation by application
  • Near-term and Pre-term Infants PPHN
  • Children and Adult ARDS
  • Other Diseases
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Mallinckrodt
  • Linde
  • Air Liquide
Key Questions Addressed in this Report

What is the 10-year outlook for the global Medical Inhaled Nitric Oxide market?

What factors are driving Medical Inhaled Nitric Oxide market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Medical Inhaled Nitric Oxide market opportunities vary by end market size?

How does Medical Inhaled Nitric Oxide break out no concentration, application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Medical Inhaled Nitric Oxide Annual Sales 2019-2030
  2.1.2 World Current & Future Analysis for Medical Inhaled Nitric Oxide by Geographic Region, 2019, 2023 & 2030
  2.1.3 World Current & Future Analysis for Medical Inhaled Nitric Oxide by Country/Region, 2019, 2023 & 2030
2.2 Medical Inhaled Nitric Oxide Segment by NO Concentration
  2.2.1 800 ppm
  2.2.2 100 ppm
  2.2.3 Others
2.3 Medical Inhaled Nitric Oxide Sales by NO Concentration
  2.3.1 Global Medical Inhaled Nitric Oxide Sales Market Share by NO Concentration (2019-2024)
  2.3.2 Global Medical Inhaled Nitric Oxide Revenue and Market Share by NO Concentration (2019-2024)
  2.3.3 Global Medical Inhaled Nitric Oxide Sale Price by NO Concentration (2019-2024)
2.4 Medical Inhaled Nitric Oxide Segment by Application
  2.4.1 Near-term and Pre-term Infants PPHN
  2.4.2 Children and Adult ARDS
  2.4.3 Other Diseases
2.5 Medical Inhaled Nitric Oxide Sales by Application
  2.5.1 Global Medical Inhaled Nitric Oxide Sale Market Share by Application (2019-2024)
  2.5.2 Global Medical Inhaled Nitric Oxide Revenue and Market Share by Application (2019-2024)
  2.5.3 Global Medical Inhaled Nitric Oxide Sale Price by Application (2019-2024)

3 GLOBAL MEDICAL INHALED NITRIC OXIDE BY COMPANY

3.1 Global Medical Inhaled Nitric Oxide Breakdown Data by Company
  3.1.1 Global Medical Inhaled Nitric Oxide Annual Sales by Company (2019-2024)
  3.1.2 Global Medical Inhaled Nitric Oxide Sales Market Share by Company (2019-2024)
3.2 Global Medical Inhaled Nitric Oxide Annual Revenue by Company (2019-2024)
  3.2.1 Global Medical Inhaled Nitric Oxide Revenue by Company (2019-2024)
  3.2.2 Global Medical Inhaled Nitric Oxide Revenue Market Share by Company (2019-2024)
3.3 Global Medical Inhaled Nitric Oxide Sale Price by Company
3.4 Key Manufacturers Medical Inhaled Nitric Oxide Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Medical Inhaled Nitric Oxide Product Location Distribution
  3.4.2 Players Medical Inhaled Nitric Oxide Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR MEDICAL INHALED NITRIC OXIDE BY GEOGRAPHIC REGION

4.1 World Historic Medical Inhaled Nitric Oxide Market Size by Geographic Region (2019-2024)
  4.1.1 Global Medical Inhaled Nitric Oxide Annual Sales by Geographic Region (2019-2024)
  4.1.2 Global Medical Inhaled Nitric Oxide Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Medical Inhaled Nitric Oxide Market Size by Country/Region (2019-2024)
  4.2.1 Global Medical Inhaled Nitric Oxide Annual Sales by Country/Region (2019-2024)
  4.2.2 Global Medical Inhaled Nitric Oxide Annual Revenue by Country/Region (2019-2024)
4.3 Americas Medical Inhaled Nitric Oxide Sales Growth
4.4 APAC Medical Inhaled Nitric Oxide Sales Growth
4.5 Europe Medical Inhaled Nitric Oxide Sales Growth
4.6 Middle East & Africa Medical Inhaled Nitric Oxide Sales Growth

5 AMERICAS

5.1 Americas Medical Inhaled Nitric Oxide Sales by Country
  5.1.1 Americas Medical Inhaled Nitric Oxide Sales by Country (2019-2024)
  5.1.2 Americas Medical Inhaled Nitric Oxide Revenue by Country (2019-2024)
5.2 Americas Medical Inhaled Nitric Oxide Sales by NO Concentration
5.3 Americas Medical Inhaled Nitric Oxide Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Medical Inhaled Nitric Oxide Sales by Region
  6.1.1 APAC Medical Inhaled Nitric Oxide Sales by Region (2019-2024)
  6.1.2 APAC Medical Inhaled Nitric Oxide Revenue by Region (2019-2024)
6.2 APAC Medical Inhaled Nitric Oxide Sales by NO Concentration
6.3 APAC Medical Inhaled Nitric Oxide Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Medical Inhaled Nitric Oxide by Country
  7.1.1 Europe Medical Inhaled Nitric Oxide Sales by Country (2019-2024)
  7.1.2 Europe Medical Inhaled Nitric Oxide Revenue by Country (2019-2024)
7.2 Europe Medical Inhaled Nitric Oxide Sales by NO Concentration
7.3 Europe Medical Inhaled Nitric Oxide Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Medical Inhaled Nitric Oxide by Country
  8.1.1 Middle East & Africa Medical Inhaled Nitric Oxide Sales by Country (2019-2024)
  8.1.2 Middle East & Africa Medical Inhaled Nitric Oxide Revenue by Country (2019-2024)
8.2 Middle East & Africa Medical Inhaled Nitric Oxide Sales by NO Concentration
8.3 Middle East & Africa Medical Inhaled Nitric Oxide Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Medical Inhaled Nitric Oxide
10.3 Manufacturing Process Analysis of Medical Inhaled Nitric Oxide
10.4 Industry Chain Structure of Medical Inhaled Nitric Oxide

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Medical Inhaled Nitric Oxide Distributors
11.3 Medical Inhaled Nitric Oxide Customer

12 WORLD FORECAST REVIEW FOR MEDICAL INHALED NITRIC OXIDE BY GEOGRAPHIC REGION

12.1 Global Medical Inhaled Nitric Oxide Market Size Forecast by Region
  12.1.1 Global Medical Inhaled Nitric Oxide Forecast by Region (2025-2030)
  12.1.2 Global Medical Inhaled Nitric Oxide Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Medical Inhaled Nitric Oxide Forecast by NO Concentration
12.7 Global Medical Inhaled Nitric Oxide Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Mallinckrodt
  13.1.1 Mallinckrodt Company Information
  13.1.2 Mallinckrodt Medical Inhaled Nitric Oxide Product Portfolios and Specifications
  13.1.3 Mallinckrodt Medical Inhaled Nitric Oxide Sales, Revenue, Price and Gross Margin (2019-2024)
  13.1.4 Mallinckrodt Main Business Overview
  13.1.5 Mallinckrodt Latest Developments
13.2 Linde
  13.2.1 Linde Company Information
  13.2.2 Linde Medical Inhaled Nitric Oxide Product Portfolios and Specifications
  13.2.3 Linde Medical Inhaled Nitric Oxide Sales, Revenue, Price and Gross Margin (2019-2024)
  13.2.4 Linde Main Business Overview
  13.2.5 Linde Latest Developments
13.3 Air Liquide
  13.3.1 Air Liquide Company Information
  13.3.2 Air Liquide Medical Inhaled Nitric Oxide Product Portfolios and Specifications
  13.3.3 Air Liquide Medical Inhaled Nitric Oxide Sales, Revenue, Price and Gross Margin (2019-2024)
  13.3.4 Air Liquide Main Business Overview
  13.3.5 Air Liquide Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION


LIST OF TABLES

Table 1. Medical Inhaled Nitric Oxide Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Medical Inhaled Nitric Oxide Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of 800 ppm
Table 4. Major Players of 100 ppm
Table 5. Major Players of Others
Table 6. Global Medical Inhaled Nitric Oxide Sales by NO Concentration (2019-2024) & (M L)
Table 7. Global Medical Inhaled Nitric Oxide Sales Market Share by NO Concentration (2019-2024)
Table 8. Global Medical Inhaled Nitric Oxide Revenue by NO Concentration (2019-2024) & ($ million)
Table 9. Global Medical Inhaled Nitric Oxide Revenue Market Share by NO Concentration (2019-2024)
Table 10. Global Medical Inhaled Nitric Oxide Sale Price by NO Concentration (2019-2024) & (US$/L)
Table 11. Global Medical Inhaled Nitric Oxide Sales by Application (2019-2024) & (M L)
Table 12. Global Medical Inhaled Nitric Oxide Sales Market Share by Application (2019-2024)
Table 13. Global Medical Inhaled Nitric Oxide Revenue by Application (2019-2024)
Table 14. Global Medical Inhaled Nitric Oxide Revenue Market Share by Application (2019-2024)
Table 15. Global Medical Inhaled Nitric Oxide Sale Price by Application (2019-2024) & (US$/L)
Table 16. Global Medical Inhaled Nitric Oxide Sales by Company (2019-2024) & (M L)
Table 17. Global Medical Inhaled Nitric Oxide Sales Market Share by Company (2019-2024)
Table 18. Global Medical Inhaled Nitric Oxide Revenue by Company (2019-2024) ($ Millions)
Table 19. Global Medical Inhaled Nitric Oxide Revenue Market Share by Company (2019-2024)
Table 20. Global Medical Inhaled Nitric Oxide Sale Price by Company (2019-2024) & (US$/L)
Table 21. Key Manufacturers Medical Inhaled Nitric Oxide Producing Area Distribution and Sales Area
Table 22. Players Medical Inhaled Nitric Oxide Products Offered
Table 23. Medical Inhaled Nitric Oxide Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Medical Inhaled Nitric Oxide Sales by Geographic Region (2019-2024) & (M L)
Table 27. Global Medical Inhaled Nitric Oxide Sales Market Share Geographic Region (2019-2024)
Table 28. Global Medical Inhaled Nitric Oxide Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Medical Inhaled Nitric Oxide Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Medical Inhaled Nitric Oxide Sales by Country/Region (2019-2024) & (M L)
Table 31. Global Medical Inhaled Nitric Oxide Sales Market Share by Country/Region (2019-2024)
Table 32. Global Medical Inhaled Nitric Oxide Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Medical Inhaled Nitric Oxide Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Medical Inhaled Nitric Oxide Sales by Country (2019-2024) & (M L)
Table 35. Americas Medical Inhaled Nitric Oxide Sales Market Share by Country (2019-2024)
Table 36. Americas Medical Inhaled Nitric Oxide Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas Medical Inhaled Nitric Oxide Revenue Market Share by Country (2019-2024)
Table 38. Americas Medical Inhaled Nitric Oxide Sales by Type (2019-2024) & (M L)
Table 39. Americas Medical Inhaled Nitric Oxide Sales by Application (2019-2024) & (M L)
Table 40. APAC Medical Inhaled Nitric Oxide Sales by Region (2019-2024) & (M L)
Table 41. APAC Medical Inhaled Nitric Oxide Sales Market Share by Region (2019-2024)
Table 42. APAC Medical Inhaled Nitric Oxide Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC Medical Inhaled Nitric Oxide Revenue Market Share by Region (2019-2024)
Table 44. APAC Medical Inhaled Nitric Oxide Sales by NO Concentration (2019-2024) & (M L)
Table 45. APAC Medical Inhaled Nitric Oxide Sales by Application (2019-2024) & (M L)
Table 46. Europe Medical Inhaled Nitric Oxide Sales by Country (2019-2024) & (M L)
Table 47. Europe Medical Inhaled Nitric Oxide Sales Market Share by Country (2019-2024)
Table 48. Europe Medical Inhaled Nitric Oxide Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe Medical Inhaled Nitric Oxide Revenue Market Share by Country (2019-2024)
Table 50. Europe Medical Inhaled Nitric Oxide Sales by Type (2019-2024) & (M L)
Table 51. Europe Medical Inhaled Nitric Oxide Sales by Application (2019-2024) & (M L)
Table 52. Middle East & Africa Medical Inhaled Nitric Oxide Sales by Country (2019-2024) & (M L)
Table 53. Middle East & Africa Medical Inhaled Nitric Oxide Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa Medical Inhaled Nitric Oxide Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa Medical Inhaled Nitric Oxide Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa Medical Inhaled Nitric Oxide Sales by NO Concentration (2019-2024) & (M L)
Table 57. Middle East & Africa Medical Inhaled Nitric Oxide Sales by Application (2019-2024) & (M L)
Table 58. Key Market Drivers & Growth Opportunities of Medical Inhaled Nitric Oxide
Table 59. Key Market Challenges & Risks of Medical Inhaled Nitric Oxide
Table 60. Key Industry Trends of Medical Inhaled Nitric Oxide
Table 61. Medical Inhaled Nitric Oxide Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Medical Inhaled Nitric Oxide Distributors List
Table 64. Medical Inhaled Nitric Oxide Customer List
Table 65. Global Medical Inhaled Nitric Oxide Sales Forecast by Region (2025-2030) & (M L)
Table 66. Global Medical Inhaled Nitric Oxide Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas Medical Inhaled Nitric Oxide Sales Forecast by Country (2025-2030) & (M L)
Table 68. Americas Medical Inhaled Nitric Oxide Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC Medical Inhaled Nitric Oxide Sales Forecast by Region (2025-2030) & (M L)
Table 70. APAC Medical Inhaled Nitric Oxide Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe Medical Inhaled Nitric Oxide Sales Forecast by Country (2025-2030) & (M L)
Table 72. Europe Medical Inhaled Nitric Oxide Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa Medical Inhaled Nitric Oxide Sales Forecast by Country (2025-2030) & (M L)
Table 74. Middle East & Africa Medical Inhaled Nitric Oxide Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global Medical Inhaled Nitric Oxide Sales Forecast by NO Concentration (2025-2030) & (M L)
Table 76. Global Medical Inhaled Nitric Oxide Revenue Forecast by NO Concentration (2025-2030) & ($ Millions)
Table 77. Global Medical Inhaled Nitric Oxide Sales Forecast by Application (2025-2030) & (M L)
Table 78. Global Medical Inhaled Nitric Oxide Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 79. Mallinckrodt Basic Information, Medical Inhaled Nitric Oxide Manufacturing Base, Sales Area and Its Competitors
Table 80. Mallinckrodt Medical Inhaled Nitric Oxide Product Portfolios and Specifications
Table 81. Mallinckrodt Medical Inhaled Nitric Oxide Sales (M L), Revenue ($ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 82. Mallinckrodt Main Business
Table 83. Mallinckrodt Latest Developments
Table 84. Linde Basic Information, Medical Inhaled Nitric Oxide Manufacturing Base, Sales Area and Its Competitors
Table 85. Linde Medical Inhaled Nitric Oxide Product Portfolios and Specifications
Table 86. Linde Medical Inhaled Nitric Oxide Sales (M L), Revenue ($ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 87. Linde Main Business
Table 88. Linde Latest Developments
Table 89. Air Liquide Basic Information, Medical Inhaled Nitric Oxide Manufacturing Base, Sales Area and Its Competitors
Table 90. Air Liquide Medical Inhaled Nitric Oxide Product Portfolios and Specifications
Table 91. Air Liquide Medical Inhaled Nitric Oxide Sales (M L), Revenue ($ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 92. Air Liquide Main Business
Table 93. Air Liquide Latest Developments

LIST OF FIGURES

Figure 1. Picture of Medical Inhaled Nitric Oxide
Figure 2. Medical Inhaled Nitric Oxide Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Medical Inhaled Nitric Oxide Sales Growth Rate 2019-2030 (M L)
Figure 7. Global Medical Inhaled Nitric Oxide Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Medical Inhaled Nitric Oxide Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of 800 ppm
Figure 10. Product Picture of 100 ppm
Figure 11. Product Picture of Others
Figure 12. Global Medical Inhaled Nitric Oxide Sales Market Share by NO Concentration in 2023
Figure 13. Global Medical Inhaled Nitric Oxide Revenue Market Share by NO Concentration (2019-2024)
Figure 14. Medical Inhaled Nitric Oxide Consumed in Near-term and Pre-term Infants PPHN
Figure 15. Global Medical Inhaled Nitric Oxide Market: Near-term and Pre-term Infants PPHN (2019-2024) & (M L)
Figure 16. Medical Inhaled Nitric Oxide Consumed in Children and Adult ARDS
Figure 17. Global Medical Inhaled Nitric Oxide Market: Children and Adult ARDS (2019-2024) & (M L)
Figure 18. Medical Inhaled Nitric Oxide Consumed in Other Diseases
Figure 19. Global Medical Inhaled Nitric Oxide Market: Other Diseases (2019-2024) & (M L)
Figure 20. Global Medical Inhaled Nitric Oxide Sales Market Share by Application (2023)
Figure 21. Global Medical Inhaled Nitric Oxide Revenue Market Share by Application in 2023
Figure 22. Medical Inhaled Nitric Oxide Sales Market by Company in 2023 (M L)
Figure 23. Global Medical Inhaled Nitric Oxide Sales Market Share by Company in 2023
Figure 24. Medical Inhaled Nitric Oxide Revenue Market by Company in 2023 ($ Million)
Figure 25. Global Medical Inhaled Nitric Oxide Revenue Market Share by Company in 2023
Figure 26. Global Medical Inhaled Nitric Oxide Sales Market Share by Geographic Region (2019-2024)
Figure 27. Global Medical Inhaled Nitric Oxide Revenue Market Share by Geographic Region in 2023
Figure 28. Americas Medical Inhaled Nitric Oxide Sales 2019-2024 (M L)
Figure 29. Americas Medical Inhaled Nitric Oxide Revenue 2019-2024 ($ Millions)
Figure 30. APAC Medical Inhaled Nitric Oxide Sales 2019-2024 (M L)
Figure 31. APAC Medical Inhaled Nitric Oxide Revenue 2019-2024 ($ Millions)
Figure 32. Europe Medical Inhaled Nitric Oxide Sales 2019-2024 (M L)
Figure 33. Europe Medical Inhaled Nitric Oxide Revenue 2019-2024 ($ Millions)
Figure 34. Middle East & Africa Medical Inhaled Nitric Oxide Sales 2019-2024 (M L)
Figure 35. Middle East & Africa Medical Inhaled Nitric Oxide Revenue 2019-2024 ($ Millions)
Figure 36. Americas Medical Inhaled Nitric Oxide Sales Market Share by Country in 2023
Figure 37. Americas Medical Inhaled Nitric Oxide Revenue Market Share by Country in 2023
Figure 38. Americas Medical Inhaled Nitric Oxide Sales Market Share by NO Concentration (2019-2024)
Figure 39. Americas Medical Inhaled Nitric Oxide Sales Market Share by Application (2019-2024)
Figure 40. United States Medical Inhaled Nitric Oxide Revenue Growth 2019-2024 ($ Millions)
Figure 41. Canada Medical Inhaled Nitric Oxide Revenue Growth 2019-2024 ($ Millions)
Figure 42. Mexico Medical Inhaled Nitric Oxide Revenue Growth 2019-2024 ($ Millions)
Figure 43. Brazil Medical Inhaled Nitric Oxide Revenue Growth 2019-2024 ($ Millions)
Figure 44. APAC Medical Inhaled Nitric Oxide Sales Market Share by Region in 2023
Figure 45. APAC Medical Inhaled Nitric Oxide Revenue Market Share by Regions in 2023
Figure 46. APAC Medical Inhaled Nitric Oxide Sales Market Share by NO Concentration (2019-2024)
Figure 47. APAC Medical Inhaled Nitric Oxide Sales Market Share by Application (2019-2024)
Figure 48. China Medical Inhaled Nitric Oxide Revenue Growth 2019-2024 ($ Millions)
Figure 49. Japan Medical Inhaled Nitric Oxide Revenue Growth 2019-2024 ($ Millions)
Figure 50. South Korea Medical Inhaled Nitric Oxide Revenue Growth 2019-2024 ($ Millions)
Figure 51. Southeast Asia Medical Inhaled Nitric Oxide Revenue Growth 2019-2024 ($ Millions)
Figure 52. India Medical Inhaled Nitric Oxide Revenue Growth 2019-2024 ($ Millions)
Figure 53. Australia Medical Inhaled Nitric Oxide Revenue Growth 2019-2024 ($ Millions)
Figure 54. China Taiwan Medical Inhaled Nitric Oxide Revenue Growth 2019-2024 ($ Millions)
Figure 55. Europe Medical Inhaled Nitric Oxide Sales Market Share by Country in 2023
Figure 56. Europe Medical Inhaled Nitric Oxide Revenue Market Share by Country in 2023
Figure 57. Europe Medical Inhaled Nitric Oxide Sales Market Share by NO Concentration (2019-2024)
Figure 58. Europe Medical Inhaled Nitric Oxide Sales Market Share by Application (2019-2024)
Figure 59. Germany Medical Inhaled Nitric Oxide Revenue Growth 2019-2024 ($ Millions)
Figure 60. France Medical Inhaled Nitric Oxide Revenue Growth 2019-2024 ($ Millions)
Figure 61. UK Medical Inhaled Nitric Oxide Revenue Growth 2019-2024 ($ Millions)
Figure 62. Italy Medical Inhaled Nitric Oxide Revenue Growth 2019-2024 ($ Millions)
Figure 63. Russia Medical Inhaled Nitric Oxide Revenue Growth 2019-2024 ($ Millions)
Figure 64. Middle East & Africa Medical Inhaled Nitric Oxide Sales Market Share by Country in 2023
Figure 65. Middle East & Africa Medical Inhaled Nitric Oxide Revenue Market Share by Country in 2023
Figure 66. Middle East & Africa Medical Inhaled Nitric Oxide Sales Market Share by NO Concentration (2019-2024)
Figure 67. Middle East & Africa Medical Inhaled Nitric Oxide Sales Market Share by Application (2019-2024)
Figure 68. Egypt Medical Inhaled Nitric Oxide Revenue Growth 2019-2024 ($ Millions)
Figure 69. South Africa Medical Inhaled Nitric Oxide Revenue Growth 2019-2024 ($ Millions)
Figure 70. Israel Medical Inhaled Nitric Oxide Revenue Growth 2019-2024 ($ Millions)
Figure 71. Turkey Medical Inhaled Nitric Oxide Revenue Growth 2019-2024 ($ Millions)
Figure 72. GCC Country Medical Inhaled Nitric Oxide Revenue Growth 2019-2024 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Medical Inhaled Nitric Oxide in 2023
Figure 74. Manufacturing Process Analysis of Medical Inhaled Nitric Oxide
Figure 75. Industry Chain Structure of Medical Inhaled Nitric Oxide
Figure 76. Channels of Distribution
Figure 77. Global Medical Inhaled Nitric Oxide Sales Market Forecast by Region (2025-2030)
Figure 78. Global Medical Inhaled Nitric Oxide Revenue Market Share Forecast by Region (2025-2030)
Figure 79. Global Medical Inhaled Nitric Oxide Sales Market Share Forecast by NO Concentration (2025-2030)
Figure 80. Global Medical Inhaled Nitric Oxide Revenue Market Share Forecast by NO Concentration (2025-2030)
Figure 81. Global Medical Inhaled Nitric Oxide Sales Market Share Forecast by Application (2025-2030)
Figure 82. Global Medical Inhaled Nitric Oxide Revenue Market Share Forecast by Application (2025-2030)


More Publications